Group One Trading’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-24,190
| Closed | -$583K | – | 3654 |
|
|
2023
Q1 | $583K | Sell |
24,190
-164,152
| -87% | -$3.96M | ﹤0.01% | 422 |
|
|
2022
Q4 | $1.99M | Buy |
188,342
+43,659
| +30% | +$461K | ﹤0.01% | 233 |
|
|
2022
Q3 | $651K | Buy |
144,683
+70,102
| +94% | +$315K | ﹤0.01% | 497 |
|
|
2022
Q2 | $298K | Buy |
+74,581
| New | +$298K | ﹤0.01% | 756 |
|
|
2022
Q1 | – | Sell |
-65,482
| Closed | -$368K | – | 3588 |
|
|
2021
Q4 | $368K | Sell |
65,482
-18,215
| -22% | -$102K | ﹤0.01% | 999 |
|
|
2021
Q3 | $536K | Sell |
83,697
-74,556
| -47% | -$477K | ﹤0.01% | 812 |
|
|
2021
Q2 | $1.33M | Buy |
+158,253
| New | +$1.33M | ﹤0.01% | 518 |
|
|
2021
Q1 | – | Sell |
-53,742
| Closed | -$910K | – | 3128 |
|
|
2020
Q4 | $910K | Sell |
53,742
-16,533
| -24% | -$280K | ﹤0.01% | 488 |
|
|
2020
Q3 | $902K | Buy |
70,275
+1,199
| +2% | +$15.4K | ﹤0.01% | 391 |
|
|
2020
Q2 | $975K | Buy |
69,076
+24,950
| +57% | +$352K | ﹤0.01% | 303 |
|
|
2020
Q1 | $406K | Buy |
44,126
+37,192
| +536% | +$342K | ﹤0.01% | 397 |
|
|
2019
Q4 | $103K | Buy |
6,934
+3,008
| +77% | +$44.7K | ﹤0.01% | 793 |
|
|
2019
Q3 | $27K | Buy |
+3,926
| New | +$27K | ﹤0.01% | 973 |
|